HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D/13G Filings for Karyopharm Therapeutics Inc. (KPTI)

HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D and 13G filings for Karyopharm Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-25
09:30 am
Purchase
2024-09-30 13G Karyopharm Therapeutics Inc.
KPTI
HIGHBRIDGE CAPITAL MANAGEMENT LLC 649,659
7.200%
649,659increase
(New Position)
Filing